TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $1,133,000 | +631.0% | 1,100,000 | +117.7% | 0.01% | +500.0% |
Q3 2019 | $155,000 | -6.6% | 505,262 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $166,000 | -50.2% | 505,262 | 0.0% | 0.00% | -50.0% |
Q1 2019 | $333,000 | -61.5% | 505,262 | 0.0% | 0.00% | -71.4% |
Q4 2018 | $864,000 | -70.5% | 505,262 | 0.0% | 0.01% | -63.2% |
Q3 2018 | $2,931,000 | -4.6% | 505,262 | -1.3% | 0.02% | -17.4% |
Q2 2018 | $3,071,000 | +4.2% | 511,763 | +25.0% | 0.02% | -8.0% |
Q1 2018 | $2,947,000 | -0.7% | 409,323 | 0.0% | 0.02% | -3.8% |
Q4 2017 | $2,968,000 | +39.3% | 409,323 | -1.1% | 0.03% | +52.9% |
Q3 2017 | $2,131,000 | +17.1% | 413,697 | 0.0% | 0.02% | +6.2% |
Q2 2017 | $1,820,000 | -28.5% | 413,697 | 0.0% | 0.02% | -23.8% |
Q1 2017 | $2,544,000 | +8.9% | 413,697 | 0.0% | 0.02% | -8.7% |
Q4 2016 | $2,337,000 | -61.8% | 413,697 | 0.0% | 0.02% | -58.9% |
Q3 2016 | $6,120,000 | +221.8% | 413,697 | +95.3% | 0.06% | +180.0% |
Q2 2016 | $1,902,000 | -2.9% | 211,792 | 0.0% | 0.02% | -4.8% |
Q1 2016 | $1,959,000 | -26.7% | 211,792 | 0.0% | 0.02% | -4.5% |
Q4 2015 | $2,671,000 | +225.3% | 211,792 | +236.1% | 0.02% | +175.0% |
Q3 2015 | $821,000 | – | 63,014 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VR Adviser, LLC | 4,040,000 | $59,428,000 | 8.74% |
Fairmount Funds Management LLC | 1,478,181 | $21,744,000 | 7.78% |
COMMODORE CAPITAL LP | 852,871 | $12,546,000 | 6.82% |
Ghost Tree Capital, LLC | 1,950,000 | $28,685,000 | 6.39% |
Endurant Capital Management LP | 655,741 | $9,646,000 | 3.48% |
FRAZIER MANAGEMENT LLC | 3,053,107 | $44,879,000 | 3.46% |
ACUTA CAPITAL PARTNERS, LLC | 803,000 | $11,812,000 | 3.21% |
NEA Management Company, LLC | 5,736,363 | $84,382,000 | 2.23% |
Tri Locum Partners LP | 296,838 | $4,366,000 | 1.59% |
Avidity Partners Management LP | 3,185,200 | $46,854,000 | 1.52% |